Originally published on Huffington Post. DSA member Benjamin Fong wrote for Huffington Post about the corporate powerhouses Amazon, JPMorgan Chase, and Berkshire Hathaway exploring a “disruptive” health care strategy for its own US-based employees, which would provide (ostensibly low-quality) care at a low cost, supposedly free of profit motives. Fong isn’t having it. And indeed, in spite of the seemingly progressive rhetoric (“improving employee satisfaction,” “free from profit-making incentives,” etc.), every commentator on this proposal saw it quite clearly as a business decision. The New York Times even compared it to “classic disruption,” where a company enters “a market with a product that is lower in value than that of market incumbents, but much lower in cost.” That a proposed nonprofit health care company would be immediately and so easily compared to “classic disrupters, like Southwest Airlines, MP3s or Japanese carmakers,” is a good indication that most people doubt that health is really the goal here. Read the rest at Huffington Post.